External Use Authorized ...
Becoming a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
Earlier from Clarity Pharmaceuticals
- Ceasing to be a substantial holder
- Bioshares Biotech Summit Presentation
- Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses
- Notification regarding unquoted securities - CU6
- SECuRE update
Later from Clarity Pharmaceuticals
- Preliminary Final Report
- Date of Annual General Meeting 25 November 2026
- Annual Report to shareholders
- Appendix 4G
- Corporate governance statement
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals